TRAVATAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Travatan, and when can generic versions of Travatan launch?
Travatan is a drug marketed by Alcon Pharms Ltd and Sandoz and is included in two NDAs. There are three patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in TRAVATAN is travoprost. There are fifteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the travoprost profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Travatan
A generic version of TRAVATAN was approved as travoprost by CHARTWELL RX on March 1st, 2013.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRAVATAN?
- What are the global sales for TRAVATAN?
- What is Average Wholesale Price for TRAVATAN?
Summary for TRAVATAN
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Clinical Trials: | 53 |
Patent Applications: | 3,814 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TRAVATAN |
Drug Sales Revenues: | Drug sales revenues for TRAVATAN |
DailyMed Link: | TRAVATAN at DailyMed |
![TRAVATAN drug patent expirations Drug patent expirations by year for TRAVATAN](/p/graph/s/t/TRAVATAN-patent-expirations.png)
![Drug Prices for TRAVATAN](/p/graph/drug-price/TRAVATAN.png)
Recent Clinical Trials for TRAVATAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The University of Hong Kong | N/A |
Laboratorios Sophia S.A de C.V. | Phase 1 |
Novartis Pharmaceuticals | Phase 4 |
Paragraph IV (Patent) Challenges for TRAVATAN
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
TRAVATAN | Ophthalmic Solution | travoprost | 0.004% | 021257 | 1 | 2008-11-28 |
US Patents and Regulatory Information for TRAVATAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon Pharms Ltd | TRAVATAN | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021257-001 | Mar 16, 2001 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sandoz | TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994-001 | Sep 21, 2006 | AT | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Sandoz | TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994-001 | Sep 21, 2006 | AT | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Sandoz | TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994-001 | Sep 21, 2006 | AT | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRAVATAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alcon Pharms Ltd | TRAVATAN | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021257-001 | Mar 16, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Alcon Pharms Ltd | TRAVATAN | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021257-001 | Mar 16, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Alcon Pharms Ltd | TRAVATAN | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021257-001 | Mar 16, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Alcon Pharms Ltd | TRAVATAN | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021257-001 | Mar 16, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Alcon Pharms Ltd | TRAVATAN | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021257-001 | Mar 16, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Alcon Pharms Ltd | TRAVATAN | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021257-001 | Mar 16, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
EU/EMA Drug Approvals for TRAVATAN
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Novartis Europharm Limited | Izba | travoprost | EMEA/H/C/002738 Decrease of elevated intraocular pressure in adult patients with ocular hypertension or open-angle glaucoma (see section 5.1). Decrease of elevated intraocular pressure in paediatric patients aged 3 years to < 18 years with ocular hypertension or paediatric glaucoma. |
Authorised | no | no | no | 2014-02-20 | |
Novartis Europharm Limited | Travatan | travoprost | EMEA/H/C/000390 Decrease of elevated intraocular pressure in adult patients with ocular hypertension or open-angle glaucoma (see section 5.1).Decrease of elevated intraocular pressure in paediatric patients aged 2 months to < 18 years with ocular hypertension or paediatric glaucoma (see section 5.1). |
Authorised | no | no | no | 2001-11-27 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for TRAVATAN
See the table below for patents covering TRAVATAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2162951 | ⤷ Sign Up | |
Australia | 6877994 | ⤷ Sign Up | |
Japan | H10182465 | TOPICAL OPHTHALMIC PHARMACEUTICAL COMPOSITION FOR TREATING GLAUCOMA AND OCULAR HYPERTENSION | ⤷ Sign Up |
Japan | H07165703 | TOPICAL COLLYRIUM COMPOSITION FOR TREATMENT OF GLAUCOMA AND HIGH INTRAOCULAR TENSION | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 0003736 | ⤷ Sign Up | |
Denmark | 0812198 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for TRAVATAN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1514548 | PA2014029 | Lithuania | ⤷ Sign Up | PRODUCT NAME: TRAVOPROSTUM; REGISTRATION NO/DATE: EU/1/01/199/001 - EU/1/01/199/002 20011129 |
1920764 | 12C0045 | France | ⤷ Sign Up | PRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EU/1/01/199/001 20011127 |
1920764 | C01920764/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: TRAVOPROST; REGISTRATION NUMBER/DATE: SWISSMEDIC 55910 22.05.2002 |
1920764 | 92058 | Luxembourg | ⤷ Sign Up | 92058, EXPIRES: 20161127 |
1920764 | PA2012017 | Lithuania | ⤷ Sign Up | PRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127 |
1514548 | C300671 | Netherlands | ⤷ Sign Up | PRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EG EU/1/01/199/001-002 20011128 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |